Skip to main content
OpenTrials

Clinical trial condition

Metastatic

Explore clinical trials studying Metastatic. Study availability and eligibility vary by location and protocol.

19 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Metastatic trial results

Recruiting

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

NCT06007937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering West Harrison (All Protocol Activities) Harrison, New York, United States
View Trial Details
Recruiting

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

NCT04333706

Conditions
Breast, Cancer, Disseminated Tumor Cell, +7 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UF Health Gainesville, Florida, United States
View Trial Details
Recruiting

PRE-I-SPY Phase I/Ib Oncology Platform Program

NCT05868226

Conditions
Breast Diseases, Breast Neoplasms, ER Positive Breast Cancer, +29 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Completed

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

NCT05673811

Conditions
Metastatic, Neoplasm Metastasis, Neoplasms, +4 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of California - Davis Cancer Center Sacramento, California, United States
  • University of Louisville - Brown Cancer Center Louisville, Kentucky, United States
  • Weill Cornell Medical Center New York, United States
View all 17 locations
View Trial Details

Related conditions